Bypassing the Blood-Brain-Barrier
Kurve Therapeutics is at the forefront of a new era of central nervous system (CNS) disorder treatments. We are an innovative specialty-drug and medical technology company focused on developing treatments for neurodegenerative diseases.
Kurve Therapeutics is taking bold steps to be market-ready — we are ready for Phase III clinical trials in three separate target diseases. Our next-generation technology has been used in five double-blind placebo-controlled Phase II studies and is ready for Phase III with Alzheimer’s patients.
The Upcoming Regulation A Offering:
What does an investment in Kurve Therapeutics mean?
Help millions of people.
Impact a vast market.
Reshape the medical field.
ViaNase™: Intelligent Delivery, the Future of CNS Treatments
Our medtech innovation features: